Eprosartan Side Effects
Medically reviewed by Drugs.com. Last updated on Sep 1, 2024.
Applies to eprosartan: oral tablet.
Important warnings
This medicine can cause some serious health issues
Oral route (tablet)
Drugs that act on the renin-angiotensin system can cause injury or death to the developing fetus when used during the second and third trimesters.
When pregnancy is confirmed, discontinue treatment immediately.
Serious side effects of eprosartan
Along with its needed effects, eprosartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking eprosartan:
Less common side effects
- burning or painful urination or changes in urinary frequency
- cough
- fever
- sore throat
Rare side effects
- dizziness, lightheadedness, or fainting
- swollen face, lips, limbs, or tongue
Other side effects of eprosartan
Some side effects of eprosartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common or rare side effects
- abdominal or stomach pain
- joint pain
- unusual tiredness
For healthcare professionals
Applies to eprosartan: oral tablet.
General adverse events
The most common adverse reactions were headache and unspecific gastrointestinal complaints.[Ref]
Nervous system
- Very common (10% or more): Headache (up to 11%)
- Common (1% to 10%): Dizziness
- Frequency not reported: Ataxia, migraine, neuritis, paresthesia, somnolence, tremor, vertigo, tinnitus[Ref]
Gastrointestinal
- Common (1% to 10%): Unspecific gastrointestinal complaints, abdominal pain, diarrhea, dyspepsia
- Frequency not reported: Constipation, dry mouth, esophagitis, flatulence, gastritis, gastroenteritis, gingivitis, nausea, periodontitis, toothache, vomiting[Ref]
Respiratory
- Common (1% to 10%): Rhinitis, upper respiratory tract infection, pharyngitis, coughing, sinusitis, dyspnea, bronchitis
- Frequency not reported: Asthma, epistaxis[Ref]
Other
- Common (1% to 10%): Asthenia, injury, chest pain, fatigue, pain
- Uncommon (0.1% to 1%): Facial edema
- Frequency not reported: Substernal chest pain, peripheral edema, fever, influenza-like symptoms, malaise[Ref]
Musculoskeletal
- Common (1% to 10%): Myalgia, arthralgia, back pain
- Frequency not reported: Rigors, creatine phosphokinase increased, arthritis, arthritis aggravated, arthrosis, skeletal pain, tendinitis, leg cramps[Ref]
Cardiovascular
- Common (1% to 10%): Palpitation, dependent edema
- Uncommon (0.1% to 1%): Hypotension
- Frequency not reported: Hot flushes, angina pectoris, bradycardia, ECG abnormal, ECG specific abnormal, extrasystoles, atrial fibrillation, tachycardia, peripheral ischemia[Ref]
Hematologic
- Common (1% to 10%): Neutrophils 1500/mm3 or less
- Uncommon (0.1% to 1%): Hemoglobin decreased greater than 20%, WBC count of 3000/mm3 or less, platelets 100 x 10(9)/L or less
- Frequency not reported: Anemia, leukopenia[Ref]
Metabolic
- Common (1% to 10%): Hypertriglyceridemia
- Uncommon (0.1% to 1%): Potassium 5.6 mmol/L or greater
- Frequency not reported: Alcohol intolerance, anorexia, diabetes mellitus, gout, hypercholesterolemia, hyperglycemia, hyperkalemia, hypokalemia, hyponatremia[Ref]
Dermatologic
- Common (1% to 10%): Allergic skin reactions
- Uncommon (0.1% to 1%): Angioedema
- Frequency not reported: Purpura, eczema, furunculosis, pruritus, rash, maculopapular rash, sweating increased[Ref]
Immunologic
- Common (1% to 10%): Viral infection
- Uncommon (0.1% to 1%): Hypersensitivity
- Frequency not reported: Herpes simplex, otitis externa, otitis media[Ref]
Renal
- Common (1% to 10%): BUN increased
- Uncommon (0.1% to 1%): Creatinine increased
- Frequency not reported: Renal calculus
- Postmarketing reports: Impaired renal function, renal failure[Ref]
Genitourinary
- Common (1% to 10%): Urinary tract infection
- Frequency not reported: Glycosuria, albuminuria, cystitis, hematuria, micturition frequency, polyuria, urinary incontinence[Ref]
Psychiatric
- Common (1% to 10%): Depression
- Frequency not reported: Anxiety, insomnia, nervousness[Ref]
Hepatic
- Uncommon (0.1% to 1%): ALT greater than 3.5 times the upper limit of normal
- Frequency not reported: Serum glutamic oxaloacetic transaminase (SGOT) increased, serum glutamic pyruvic transaminase (SGPT) increased, ALT increased, AST increased, alkaline phosphatase increased[Ref]
Ocular
- Frequency not reported: Conjunctivitis, vision abnormal, xerophthalmia[Ref]
References
1. (2001) "Product Information. Teveten (eprosartan)." SmithKline Beecham
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
More about eprosartan
- Check interactions
- Compare alternatives
- Drug images
- Dosage information
- During pregnancy
- Drug class: angiotensin receptor blockers
- Breastfeeding
Patient resources
Other brands
Related treatment guides
Further information
Eprosartan side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.